Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:32 PM
Ignite Modification Date:
2025-12-24 @ 10:32 PM
NCT ID:
NCT02713035
Eligibility Criteria:
Inclusion Criteria:
1. children presenting to the pediatric dermatology clinic;
2. current or new diagnosis of eczema or AD;
3. between the ages of 4 and 12;
4. excoriation is reported by the patient or parent or noted by the clinical staff to be a prominent issues within the past month.
Exclusion Criteria:
1. inability to complete English-language questionnaires;
2. patients requiring systemic immunosuppressives such as systemic prednisone, methotrexate, azathioprine, mycophenolate mofetil, or cyclosporine;
3. Patients with known comorbidities that cause immunodeficiency, such as HIV, treatment with chemotherapy, or genetic syndromes;
4. Patients who are being treated by a mental health provider (e.g., counselor, psychologist) or psychiatrist for issues specifically related to excoriation.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
4 Years
Maximum Age:
12 Years
Study:
NCT02713035
Study Brief:
Protocol Section:
NCT02713035